Objective-Lmo (LIM-domain-only)2 transcription factor is involved in hematopoiesis and vascular remodeling. Sphk (sphingosine kinase)1 phosphorylates sphingosine to S1P (sphingosine-1-phosphate). We hypothesized that Lmo2 regulates Sphk1 to promote endothelial cell (EC) migration and vascular development. Approach and Results-Lmo2 and Sphk1 knockdown (KD) were performed in Tg(fli1: EGFP) y1 zebrafish and in human umbilical vein EC. Rescue of phenotypes or overexpression of these factors were achieved using mRNA encoding Lmo2 or Sphk1. EC proliferation in vivo was assessed by BrdU (bromodeoxyuridine) immunostaining and fluorescence-activated cell sorter analysis of dissociated Tg(fli1:EGFP) y1 embryos. Cell migration was assessed by scratch assay in human umbilical vein EC and mouse aortic rings. Lmo2 interactions with Sphk1 promoter were assessed by ChIP-PCR (chromatin immunoprecipitation-polymerase chain reaction). Lmo2 or Sphk1 KD reduced number and length of intersegmental vessels. There was no reduction in the numbers of GFP + (green fluorescent protein) ECs after Lmo2 KD. However, reduced numbers of BrdU + GFP + nuclei were observed along the dysmorphic intersegmental vessels, accumulating instead at the sprouting origin of the intersegmental vessels. This anomaly was likely because of impaired EC migration, which was confirmed in migration assays using Lmo2 KD human umbilical vein ECs and mouse aortic rings. Both in vivo and in vitro, Lmo2 KD reduced Sphk1 gene expression, associated with less Lmo2 binding to the Sphk1 promoter as assessed by ChIP-PCR. Sphk1 mRNA rescued the Lmo2 KD phenotype. Conclusions-Our data showed that Lmo2 is necessary for Sphk1 gene expression in ECs. Lmo2 KD reduced Lmo2-Sphk1 gene interaction, impaired intersegmental vessels formation, and reduced cell migration. We identified for the first time 
D
uring embryogenesis, blood vessel formation requires vasculogenesis and angiogenesis. 1 Vasculogenesis is the process by which primitive mesodermal cells home to various tissues and differentiate into endothelial cells (ECs) to form the primary capillary network. Angiogenesis is the process by which ECs sprout from preexisting vessels, proliferate, migrate, and assemble into new blood vessels. Migration of ECs is a key process during angiogenesis, in which the directionality of the process is regulated by chemotactic, haptotactic, and mechanotactic stimuli that can activate several signaling pathways converging on cytoskeletal remodeling. 2 
See accompanying editorial on page 1806
Lmo (LIM-domain-only)2 (previously known as RBTN2 or TTG2) is a transcription factor essential in both hematopoietic 3 and endothelial pathways. 4 Lmo2 controls hematopoietic cell fate via protein-protein interactions with key DNA replication proteins MCM6 (mini-chromosome maintenance-6), PRIM1 (primase-1), and POLD1 (polymerase delta-1), 5, 6 as well as chromatin-modifying enzymes BAZ1A (bromodomain adjacent to zinc finger domain protein-1A), SETD8 (su(var), enhancer of zeste, trithorax-D8), MYST2 (Moz, YBF2, Sas2p, Tip-2), and UHRF1 (ubiquitin-like, containing PHD and RING finger domains-1). [7] [8] [9] Lmo2 acts as a bridging molecule through its LIM-domain zinc-finger-like structures, 10 and its canonical function is to assemble a DNA-binding complex, which includes the TAL1 (T-cell acute lymphocytic leukemia-1), E47 (England47), GATA1, and Ldb1 (Lim-domain binding-1) proteins in erythroid cells. 11 In ECs, a similar multicomplex upregulates VE-cadherin gene expression through direct binding to the VE-cadherin promoter. 12 Lmo2 is not required for de novo vessel formation during early embryogenesis but is needed for remodeling of vascular networks 4 and is normally expressed in vascular endothelium. 13 However, the role of Lmo2 as well as Lmo2-regulated genes in EC development and migration has not been fully characterized.
In this article, we provide evidence that during vascular development, Lmo2 plays a critical role in the generation of the intersegmental vessels (ISVs). We find that this critical role of Lmo2 is because of its regulation of EC migration, an effect mediated in part by S1P (sphingosine-1 phosphate).
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Lmo2 Modulates Zebrafish Vascular Development
In our experiments, we used the Tg(fli1: EGFP) y1 zebrafish line to follow vascular development in vivo. Lmo2-targeted morpholino injection did not affect the gross morphology of the zebrafish, as observed at 24 and 48 hours postfertilization (hpf) ( Figure 1A ; Figure I in the online-only Data Supplement). However, Lmo2 knockdown (KD) significantly impaired the formation of ISVs ( Figure 1B and 1D ), but not the larger conduits, compared with the mismatch morpholino control group. Lmo2 mRNA coinjected with Lmo2 morpholino rescued the phenotype observed in Lmo2 KD embryos, confirming that the impairment of ISV generation and patterning was specifically caused by Lmo2 KD. Western blotting confirmed the Lmo2 KD in morpholino-injected embryos ( Figure 1C ), whereas coinjection of morpholino with Lmo2 mRNA rescued Lmo2 protein to the level of the control (mismatch morpholino). (Figure 2A ; wild-type (Wik) zebrafish line were used to correct for background signal). Because the Fli1-expressing GFP + cells are primarily of endothelial lineage, these findings suggest that Lmo2 does not regulate EC proliferation. To confirm that Lmo2 was not involved in EC proliferation and apoptosis, bromodeoxyuridine (BrdU) and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay were, respectively, used. Fluorescence-activated cell sorter analysis showed that the percentage of BrdU + GFP + (0.81%; Figure 2B ) and TUNEL + GFP + (0.34%; Figure 2C ) in Lmo2 KD embryos were not different compared with their respective controls.
Vascular Phenotype in
More evidence consistent with this notion was derived from BrdU immunostaining in whole embryos. These studies showed that the number of proliferating Fli1-expressing cells (GFP + BrdU + nuclei) is similar in control and Lmo2 KD embryos (7.5±0.9 versus 6.8±1.1 proliferating cells×100 μm of body trunk length [excluding head and tail]). In both groups of embryos, GFP + BrdU + nuclei are more evident in larger vessels ( Figure 3A and 3B, shown in dorsal aorta, cardinal vein, and dorsal longitudinal anastomotic vessels).
Vascular Phenotype in Lmo2 KD Is Associated With Impaired EC Migration
ISVs form by migration of ECs from the larger conduit. Intriguingly, the number of GFP + BrdU + nuclei found along the ISVs was reduced in Lmo2 KD compared with control embryos (9.2±0.9 versus 3.8±0.6; P≤0.05, measured in all ISVs; Figure 3C ). By contrast, the GFP + BrdU + nuclei seem to accumulate at the branch point of the ISVs in Lmo2 KD animals. These data suggest that KD of Lmo2 impaired cell migration.
To further delineate if Lmo2 may be required for EC migration, we created a stable line of Lmo2 KD human umbilical vein endothelial cells (HUVECs) using lentiviral shRNA technology followed by puromycin selection ( Figure II in the online-only Data Supplement). A control HUVEC line was generated using lentiviral scramble shRNA. Compared with control cells, the Lmo2 KD cells exhibited a 70% decrease in Lmo2 gene expression detected by real-time polymerase chain reaction (RT-PCR) and an 80% reduction in protein level by Western blot ( Figure IIA and IIB in the online-only Data Supplement). We used a scratch assay to assess EC migration. 14 We observed that Lmo2 KD significantly impaired migration of HUVECs, with an average remaining gap that was larger in Lmo2 KD (590±15 μm) compared with control cells (230±20 μm; P≤0.05; Figure 3D and 3E).
Role of Sphk1 in Zebrafish
To understand what angiogenic genes might be regulated by Lmo2, we analyzed mouse Lmo2 ChIP-Seq (chromatin immunoprecipitation-sequencing). 15 We observed Lmo2-binding peaks in the genomic region around VegfA, as well as Flt1 and Kdr (gene names of VegfR1 and VegfR2, respectively), suggesting these genes as direct targets and downstream effectors of Lmo2 ( Figure IIIA through IIIC in the onlineonly Data Supplement). We did not observe Lmo2-binding peaks in the genomic regions of VegfB, VegfC, and Flt4 (gene name of VegfR3; Figure IIIE and IIIF in the online-only Data Supplement). RT-PCR in Lmo2 KD HUVECs showed a significant reduction in VegfA gene expression but not Kdr ( Figure  IVA and IVB in the online-only Data Supplement), whereas in Lmo2 KD embryos, there was a significant reduction in Kdr gene expression but not VegfA ( Figure IVC and IVD in the online-only Data Supplement). These studies indicates that Lmo2 regulates a well-characterized angiogenic pathway.
In addition, our ChIP-Seq studies revealed 2 clear Lmo2-binding peaks in genomic region around Sphk (sphingosine kinase) 1, but not Sphk2, suggesting Sphk1 is also a direct target gene regulated by Lmo2 ( Figure V in the online-only Data Supplement). Because of the greater novelty of this observation, we further investigated the possible role of Sphk1 in the action of Lmo2.
Sphk1 phosphorylates sphingosine to S1P, a mediator of several cellular processes, including cell migration. Therefore, we hypothesized that Lmo2 could regulate EC migration by modulating Sphk1 ( Figure 4A ). There is only one group that has examined Sphk in zebrafish, finding that Sphk2, but not Sphk1, 16, 17 mediates cardiac development. Accordingly, it was necessary for us to clone and sequence Sphk1 cDNA before embarking on Sphk1 loss-of-function studies in vivo. Zebrafish Sphk1 RNA showed 100% coverage with the predicted sequence ( Figure VI in the online-only Data Supplement). In addition, the percent of identity of zebrafish Sphk1, at the protein level, with human or mouse Sphk1 was 48% or 49%, respectively ( Figure  VIA and VIB in the online-only Data Supplement).
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Lmo2 and Sphk1 Interactions in ECs and Vascular Development
The expression of Lmo2 and Sphk1 as assessed by RT-PCR is low between 0.15 and 6 hpf ( Figure 4B ). Both genes increased significantly and with similar patterns from 6 to 72 hpf. Lmo2 Bioinformatic analyses predicted that Lmo2 could bind to the sequence ACCGATAAGG, located at +3986 position of the Sphk1 gene promoter (Gene ID: 8877). We found that Sphk1 gene expression was significantly reduced in Lmo2 KD ECs ( Figure 4F ). Furthermore, a ChIP-PCR (chromatin immunoprecipitation-polymerase chain reaction) assay in HUVECs indicated that Lmo2 KD significantly decreases the binding of the Lmo2-associated complex to the Sphk1 gene. This experiment suggests that Lmo2 binds to the Sphk1 promoter to positively regulate Lmo2 expression ( Figure 4G ).
Similar to the effects of Lmo2 KD, Sphk1 KD did not affect the gross morphology of the zebrafish but significantly impaired the formation of ISVs ( Figure 5A and 5B). Again, similar to the Lmo2 KD, the Sphk1 KD HUVECs also manifested a significant impairment in cell migration compared with control (a remaining gap of 595±30 versus 260±55 μm; P≤0.05; Figure 5C and 5D). Finally, the impaired ISV formation in both Sphk1 KD zebrafish and in Lmo2 KD zebrafish could each be rescued by mRNA encoding Sphk1.
We also confirmed the relation between Lmo2 and S1P, of which Sphk1 is an important mediator, by studying cell migration in mice using an additional model, the aortic ring assay (Figure 6 ). Treatment with Lmo2 siRNA reduced cell migration in aortic rings, whereas the addition of S1P partially rescued cell migration ( Figure 6A and 6B) . Sk1-I, a selective inhibitor of Sphk1, also impaired cell migration, whereas coincubation with S1P rescued cell migration to a level similar to the control ( Figure 6A and 6B). These data strongly support a model whereby Lmo2 upregulation of Sphk1 plays a critical role in EC migration and ISV generation.
Discussion
Salient Findings
The major new findings of our study are that (1) Lmo2 regulates the generation of ISVs in zebrafish, a phenomenon that is known to be dependent on angiogenesis; (2) the effect of Lmo2 on ISV generation seems to be mediated by its promotion of EC migration; (3) the effect of Lmo2 to enhance EC migration and ISV formation is mediated at least in part by its upregulation of Sphk1. 
Role of Lmo2 in Adult Angiogenesis
Angiogenesis is required in many physiological and pathological conditions, including embryonic development, wound healing, tissue regeneration, and tumor growth. 18 The process is characterized by a highly regulated balance between pro-and antiangiogenic agents and involves a cascade of events in which the migration of capillary ECs is an essential component. 2 Indeed, Lmo2 has been proposed as a marker of vascular differentiation in a variety of native and neoplastic tissues. 13 In a previous report, we showed that Lmo2 regulates proliferation of adult ECs by the control of the endothelial G1/S transition and of the transcriptional regulation of CDK (cyclin-dependent kinase) 2, CDK4, Cyclin D1, and Cyclin A1. 19 We also showed that Lmo2 affected EC proliferation and tailfin regeneration in the adult zebrafish.
New Insights Regarding the Role of Lmo2 in Developmental Angiogenesis
In the present study, we investigated the role of Lmo2 during zebrafish vascular development. Uniquely, the zebrafish embryo survives and develops even in complete absence of blood circulation until several days old, 20, 21 gaining sufficient oxygenation via diffusion from the environment. This facilitates phenotypic analysis of animals with even severe circulation defects. 22 Indeed, Lmo2 KD embryos were viable, and there was no significant alteration in gross morphology, despite a severe vascular anomaly. Specifically, Lmo2 KD substantially reduced the number and length of ISVs. This finding is consistent with a previous observation in murine embryogenesis that the primitive vascular network formed by vasculogenesis does not undergo maturation into functional vascular structures in the absence of Lmo2. It is known that ISVs form by angiogenesis, a process that is known to involve proliferation, survival, migration, and differentiation of ECs. However, as opposed to our studies in adult angiogenesis, Lmo2 KD did not have a significant effect on EC proliferation. Specifically, Lmo2 KD did not substantially reduce GFP + cells in the Tg(fli1:EGFP) y1 embryos. This did not involve proliferation nor apoptosis because the percentages of BrdU + GFP + and TUNEL + GFP + cells were similar in Lmo2 KD and control embryos. Furthermore, BrdU immunostaining in the whole embryo also showed that the total number of BrdU + GFP + was not different in Lmo2 KD embryos, further supporting the notion that Lmo2 was not critical for EC proliferation in the embryo.
In Lmo2 KD embryos, the majority of BrdU + GFP + cells seemed to accumulate at the branch point of ISVs, suggesting that they failed to migrate to form ISVs. 23 To confirm our hypothesis, we used a well-established EC migration assay in vitro. These studies revealed that Lmo2 KD impaired the ability of HUVECs to migrate. The data suggest that Lmo2 governs EC migration and that during developmental angiogenesis, the effect of Lmo2 on EC migration (rather than proliferation) plays a predominant role in ISV formation.
Sphk1 Mediates the Effect of Lmo2 on Developmental Angiogenesis
We were interested to understand the gene(s) downstream of Lmo2 that played a role in EC migration. 11, 24 Bioinformatic analysis of mouse Lmo2 ChIP-Seq data showed that Lmo2 complex binds to both the VegfA, Flt1, and Kdr, as well as the Sphk1 genes, each of which are good candidates for the vascular effects of Lmo2. In addition, in our previous studies Sphk1 was the most downregulated genes in a PCR array performed in Lmo2 KD HUVECs. 19 Because there are no prior studies of the role of Sphk1 in zebrafish vasculogenesis, our subsequent studies focused on this candidate.
Sphk phosphorylate sphingosine to form S1P. S1P can act as an intracellular second messenger 25 or can be released by S1P transporters, including SPNS2. 26 S1P is recognized by G protein-coupled S1P receptors, activating numerous downstream signaling pathways.
27 S1P regulates a plethora of cellular events, including cell survival, growth, differentiation, motility, and cellular architecture, 28 as well as angiogenesis and vascular integrity. [29] [30] [31] S1P pathways have been implicated in a broad range of human disease, including endothelial disorders, 32 cancer, 33 and inflammatory disorders. 34 Sphks are highly conserved 35 and widely expressed 36 enzymes. Knockout of either Sphk1 or Sphk2 generates phenotypically normal mice or zebrafish, 16, 17 suggesting that Sphk1 and Sphk2 have redundant functions that can compensate for each other. However, recent studies revealed that overexpression of Sphk2 suppressed cell growth and enhanced apoptosis in vitro, 30 in contrast to Sphk1, which generally promoted cell survival and growth. 16, 17 The contrasting effects of their overexpression may be because of their different cellular localization because Sphk1 in human is mostly localized in the cytosol, whereas Sphk2 localizes to the mitochondria, endoplasmic reticulum, and nucleus.
27
Sphk1 promotes proliferation and survival by catalyzing a reaction that produces S1P and depletes levels of ceramide and sphingosine, which are proapoptotic precursors of S1P. Signaling via S1P receptors in vascular ECs results in integrin activation and focal contact assembly, events that are required for cell migration. 37 Our ChIP-PCR data in HUVECs confirmed that Lmo2 associates with Sphk1 gene. Lmo2 KD reduced Sphk1 gene expression, whereas Lmo2 mRNA treatment increased the expression of Sphk1, validating our in vitro data in HUVECs and providing further evidence of the relationship between Lmo2 and Sphk1. In addition, the mouse aortic ring assay showed that S1P rescues the effects of Lmo2 KD or Sphk1 pharmacological inhibition on cell migration. Taken together, these data provide evidence that Lmo2 modulates Sphk1. Consistent with this notion was our observation that in the zebrafish embryo, Lmo2 and Sphk1 shared a similar pattern of gene expression ≤96 hpf, with Lmo2 expression beginning somewhat earlier. To confirm the relationship between these 2 genes, we needed to design a proper KD strategy. We first sequenced the putative Sphk1 mRNA using primers based on predictions from the Pubmed and Ensembl databases. We confirmed that this predicted sequence was indeed Sphk1.
Sphk1 morpholino KD produced few effects on the global phenotype, as observed in previous studies. 16, 17 However, Sphk1 KD impaired ISV formation, with a phenotype similar, although less severe, compared with that observed after Lmo2 KD. One possible explanation for the milder phenotype is that Sphk1 and Sphk2 have redundant functions that can compensate for each other. In addition, as previously mentioned, the effects of Lmo2 are also likely to be mediated in part through the VEGF pathway. Certainly, other genes downstream of Lmo2 other than Sphk1 may be involved in the effects of Lmo2 on vascular development. It is known that Lmo2 directly interacts with transcription factors mostly of the bHLH (basic helix-loop-helix) family, SCL (stem cell leukemia)/TAL1, TAL2, and LYL1 (lymphoblastic leukemia-1) or GATA proteins. 11, 24 These interactions have not been reported to be involved in EC migration and are worthy of further examination in Lmo2-mediated EC migration. That being said, the ISV defect in Lmo2 KD zebrafish could be almost entirely rescued by Sphk1 mRNA, providing further evidence that Sphk1 mediates the effect of Lmo2 on EC migration and ISV generation. Consistent with this observation is that Sphk1 KD HUVECs manifested an impairment of EC migration, similar to that of Lmo2 KD HUVECs.
Conclusion
To conclude, in this study, we showed that Lmo2 is a determinant of vascular development in the zebrafish because of an effect on embryonic angiogenesis. As opposed to adult angiogenesis, the predominant effect of Lmo2 during embryonic angiogenesis seems to be on EC migration, rather than proliferation. These effects of Lmo2 are mediated in part by the S1P axis. It is possible that modulation of Lmo2 or Sphk1 expression or activity may provide a novel therapeutic approach either for syndromes of inadequate or for pathological angiogenesis.
